BR112021022532A2 - - Google Patents

Info

Publication number
BR112021022532A2
BR112021022532A2 BR112021022532A BR112021022532A BR112021022532A2 BR 112021022532 A2 BR112021022532 A2 BR 112021022532A2 BR 112021022532 A BR112021022532 A BR 112021022532A BR 112021022532 A BR112021022532 A BR 112021022532A BR 112021022532 A2 BR112021022532 A2 BR 112021022532A2
Authority
BR
Brazil
Application number
BR112021022532A
Other languages
Portuguese (pt)
Other versions
BR112021022532A8 (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR112021022532A2 publication Critical patent/BR112021022532A2/pt
Publication of BR112021022532A8 publication Critical patent/BR112021022532A8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/20Identification of molecular entities, parts thereof or of chemical compositions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112021022532A 2019-05-17 2020-05-15 Controle de variabilidade de analito entre amostras em matrizes biológicas complexas BR112021022532A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962849212P 2019-05-17 2019-05-17
PCT/US2020/033033 WO2020236544A1 (en) 2019-05-17 2020-05-15 Controlling intersample analyte variability in complex biological matrices

Publications (2)

Publication Number Publication Date
BR112021022532A2 true BR112021022532A2 (enExample) 2021-12-28
BR112021022532A8 BR112021022532A8 (pt) 2022-10-11

Family

ID=71016636

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021022532A BR112021022532A8 (pt) 2019-05-17 2020-05-15 Controle de variabilidade de analito entre amostras em matrizes biológicas complexas

Country Status (11)

Country Link
US (1) US12480956B2 (enExample)
EP (1) EP3969900A1 (enExample)
JP (1) JP7748877B2 (enExample)
KR (1) KR20220009948A (enExample)
CN (1) CN113826170B (enExample)
AU (1) AU2020278570A1 (enExample)
BR (1) BR112021022532A8 (enExample)
CA (1) CA3140053A1 (enExample)
IL (1) IL288014A (enExample)
SG (1) SG11202111365QA (enExample)
WO (1) WO2020236544A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220386905A1 (en) * 2021-03-02 2022-12-08 Pacific Diabetes Technologies Inc Signal processing algorithm for improving accuracy of a continuous glucose sensor and a combined continuous glucose sensor and insulin delivery cannula
GB202116626D0 (en) * 2021-11-18 2022-01-05 Fluidic Analytics Ltd Improvements in or relating to a method of analysing a component in a sample
CN117497037B (zh) * 2023-11-17 2024-08-16 上海倍谙基生物科技有限公司 一种基于广义线性模型的培养基组分敏感性分析方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69128350T2 (de) 1990-06-11 1998-03-26 Nexstar Pharmaceuticals Inc Nukleinsäureliganden
US5719273A (en) 1993-06-14 1998-02-17 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
US5945527A (en) 1996-05-30 1999-08-31 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
ES2371539T3 (es) * 2002-04-23 2012-01-04 Home Access Health Corporation Análisis cuantitativo de una muestra biológica de cantidad desconocida.
US7373256B2 (en) 2005-04-19 2008-05-13 Nicholson Jeremy K Method for the identification of molecules and biomarkers using chemical, biochemical and biological data
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
MX2010000578A (es) 2007-07-17 2010-04-30 Somalogic Inc Metodo para generar aptameros con constantes de disociacion mejoradas.
US8260556B2 (en) 2008-08-21 2012-09-04 Bio-Rad Laboratories, Inc. Calibration surface method for determination on of analyte ratios
US9551703B2 (en) * 2009-08-04 2017-01-24 The Johns Hopkins University High precision quantitative assay composition and methods of use therefor
AU2011240677B2 (en) 2010-04-12 2015-05-14 Somalogic Operating Co., Inc. 5-position modified pyrimidines and their use
JP2013528379A (ja) 2010-05-21 2013-07-11 オームクス コーポレーション Psa酵素活性アッセイによる癌の検出
CA2825196C (en) * 2011-01-21 2021-01-05 Theranos, Inc. Systems and methods for sample use maximization
EP3425090B1 (en) * 2014-02-18 2019-10-23 SomaLogic, Inc. Compositions and methods for detecting microorganisms
AU2016243656A1 (en) 2015-03-30 2017-11-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Also Published As

Publication number Publication date
SG11202111365QA (en) 2021-11-29
US20220260585A1 (en) 2022-08-18
CA3140053A1 (en) 2020-11-26
BR112021022532A8 (pt) 2022-10-11
JP2022532212A (ja) 2022-07-13
CN113826170A (zh) 2021-12-21
CN113826170B (zh) 2024-12-27
US12480956B2 (en) 2025-11-25
IL288014A (en) 2022-01-01
AU2020278570A1 (en) 2022-01-06
JP7748877B2 (ja) 2025-10-03
EP3969900A1 (en) 2022-03-23
KR20220009948A (ko) 2022-01-25
WO2020236544A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
BR112021017339A2 (enExample)
BR112021018450A2 (enExample)
BR112021017637A2 (enExample)
BR112021017892A2 (enExample)
BR112021017782A2 (enExample)
BR112021017939A2 (enExample)
BR112021017738A2 (enExample)
BR112021016996A2 (enExample)
BR112021016821A2 (enExample)
BR112021017703A2 (enExample)
BR112021017728A2 (enExample)
BR112021017234A2 (enExample)
BR112021018168A2 (enExample)
BR112021017083A2 (enExample)
BR112021017732A2 (enExample)
BR112021022532A2 (enExample)
BR112021018250A2 (enExample)
BR112021017355A2 (enExample)
BR112021018093A2 (enExample)
BR112021018102A2 (enExample)
BR112021017173A2 (enExample)
BR112021017310A2 (enExample)
BR112021017010A2 (enExample)
BR112021017949A2 (enExample)
BR112021018084A2 (enExample)

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: SOMALOGIC, INC. (US)

B25D Requested change of name of applicant approved

Owner name: SOMALOGIC OPERATING CO., INC. (US)

B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: SOMALOGIC OPERATING CO., INC. (US)

Free format text: RETIFICACAO DO DESPACHO 25.4 PUBLICADO NA RPI 2701 DE 11/10/2022:ONDE SE LE: ?EM ATENDIMENTO AO SOLICITADO NA PETICAO 870220022929 DE 29/08/2022? LEIA-SE: ?EM ATENDIMENTO AO SOLICITADO NA PETICAO 870220026241 DE 28/03/2022?

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/05/2020, OBSERVADAS AS CONDICOES LEGAIS